Literature DB >> 6374462

Cryptococcus neoformans: in vivo protection of mice by pretreatment with pyran copolymer.

R A Fromtling, H J Shadomy, A M Kaplan.   

Abstract

Synthetic polyanions have been shown to alter host resistance to infection. The anticryptococcal effect of pyran copolymer was assessed in vivo and in vitro. Pretreatment with pyran copolymer significantly extended mean survival in mice lethally infected with Cryptococcus neoformans when compared to untreated animals (p less than 0.01). The anticryptococcal effect of peritoneal exudate cells (PEC) elicited by 10% thioglycollate or pyran copolymer (25 mg/kg) was assessed in vitro. Initial percent phagocytosis of both encapsulated and non-encapsulated isolates of C. neoformans was greatest in the pyran elicited PEC. Significant killing of C. neoformans in vitro was observed only in pyran-activated PEC cultures combined with non-encapsulated cells of C. neoformans, although pyran PEC did inhibit initial growth of phagocytized encapsulated yeast cells. The protection of pyran copolymer pretreated mice from infection with C. neoformans, but the absence of significant killing of encapsulated yeast in vitro suggest a complex mechanism of host defense which may involve an activation of the reticuloendothelial system by pyran copolymer.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6374462     DOI: 10.1007/bf00436694

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  11 in total

1.  Effects of stimulation and suppression of cell-mediated immunity on experimental cryptococcosis.

Authors:  R D Diamond
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

2.  Cell-mediated immunity in Cryptococcosis.

Authors:  J R Graybill; R H Alford
Journal:  Cell Immunol       Date:  1974-10       Impact factor: 4.868

3.  A statistical survey of deep mycoses in Japan, with particular reference to autopsy cases of cryptococcosis.

Authors:  M Kanda; M Moriyama; M Ikeda; S Kojima; M Tokunaga
Journal:  Acta Pathol Jpn       Date:  1974-09

4.  Phagocytosis of Cryptococcus neoformans by alveolar macrophages.

Authors:  G S Bulmer; J R Tacker
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

Review 5.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

6.  Phagocytosis of Cryptococcus neoformans by normal and thioglycolate-activated macrophages.

Authors:  F J Swenson; T R Kozel
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

7.  Growth of Cryptococcus neoformans within human macrophages in vitro.

Authors:  R D Diamond; J E Bennett
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

8.  In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.

Authors:  T G Mitchell; L Friedman
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

9.  Immunization of mice with stable, acapsular, yeast-like mutants of Cryptococcus neoformans.

Authors:  R A Fromtling; A M Kaplan; H J Shadomy
Journal:  Sabouraudia       Date:  1983-06

10.  Decreased virulence in stable, acapsular mutants of cryptococcus neoformans.

Authors:  R A Fromtling; H J Shadomy; E S Jacobson
Journal:  Mycopathologia       Date:  1982-07-23       Impact factor: 2.574

View more
  2 in total

Review 1.  An overview of macrophage-fungal interactions.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1986-02       Impact factor: 2.574

2.  Activation of macrophages and expansion of specific T lymphocytes in the lungs of mice intratracheally inoculated with Cryptococcus neoformans.

Authors:  K Kawakami; S Kohno; N Morikawa; J Kadota; A Saito; K Hara
Journal:  Clin Exp Immunol       Date:  1994-05       Impact factor: 4.330

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.